Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Go back to Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics| (NASDAQ: SILO) | Delayed: 6.63 +0.19 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.44 | 52 Week High | $ | |||
| Open | $6.53 | 52 Week Low | $ | |||
| Day High | $6.75 | P/E | N/A | |||
| Day Low | $6.49 | EPS | $ | |||
| Volume | 19,695 | |||||

